MED — Medartis Holding AG Cashflow Statement
0.000.00%
- CH₣913.59m
- CH₣904.33m
- CH₣224.83m
- 76
- 10
- 92
- 65
Annual cashflow statement for Medartis Holding AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.944 | 6.84 | -5.78 | 0.619 | 3.53 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 0.161 | 4.36 | 3.56 | -1.17 | 17.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.49 | -6.59 | -19.8 | -2.23 | -11.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 12.6 | 21 | -3.93 | 20 | 32.1 |
Capital Expenditures | -13.1 | -10.4 | -18.8 | -18.8 | -11.1 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -9.79 | -5.49 | -34.1 | -19 | -7.97 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -22.9 | -15.9 | -52.9 | -37.8 | -19.1 |
Financing Cash Flow Items | -0.777 | -0.791 | -0.734 | -0.828 | -4.62 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.73 | -4.82 | -3.9 | 23.2 | 101 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -16.8 | -0.093 | -62 | 4.6 | 113 |